MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Inicio・Lista de Acciones・Achieve Life Sciences Inc

Achieve Life Sciences Inc

Cerrado

3.09

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.08

Máximo

3.15

Métricas clave
By Trading Economics
Ingresos	109K -13M
Margen de beneficio	-5,421.053
Empleados	25
EBITDA	-367K -12M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+330.19% upside

Dividendos
By Dow Jones
Próximas Ganancias	6 nov 2025

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	33M 161M
Apertura anterior	3.09
Cierre anterior	3.09

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

2.325 / 2.64 Soporte y Resistencia

Achieve Life Sciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

13 oct 2025, 21:45 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 oct 2025, 21:07 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 oct 2025, 17:03 UTC

Principales Movimientos del Mercado

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 oct 2025, 23:53 UTC

Charlas de Mercado

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 oct 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 oct 2025, 21:57 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 oct 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 oct 2025, 21:06 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 20:52 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 oct 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

13 oct 2025, 20:35 UTC

Adquisiciones, fusiones, absorciones

Goldman Expects to Close Deal in 1Q

13 oct 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 oct 2025, 20:29 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Buy VC Firm Industry Ventures

13 oct 2025, 19:05 UTC

Charlas de Mercado

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 oct 2025, 18:59 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 oct 2025, 18:26 UTC

Charlas de Mercado

Precious Metals Close at New Record Highs -- Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 oct 2025, 16:03 UTC

Adquisiciones, fusiones, absorciones

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 oct 2025, 15:35 UTC

Charlas de Mercado

Precious Metals Push Record Highs Further -- Market Talk

Comparación entre iguales

Cambio de precio

Achieve Life Sciences Inc Esperado

Precio Objetivo

By TipRanks

330.19% repunte

Estimación a 12 meses

Media 13.25 USD 330.19%

Máximo 20 USD

Mínimo 10 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Achieve Life Sciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Achieve Life Sciences Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

2.325 / 2.64Soporte y Resistencia

Recent bullish events outweigh bearish events.

There is one bearish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.